This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: The Hong Kong Polytechnic University. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Innovations by Albert Sun-chi Chan
Introduction
Albert Sun-chi Chan is a notable inventor based in Hong Kong, China. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of two patents, Chan is recognized for his work in developing methods and compounds that aim to combat various types of tumors.
Latest Patents
Chan's latest patents include a method of making and administering quinoline derivatives as anti-cancer agents. This invention focuses on preparing quinoline derivative compounds and administering them for the treatment of solid and non-solid tumors, particularly liver cancer. His second patent involves water-soluble polymer-based cantharimides as potentially selective anti-tumor agents. This cantharimide compound features a complex backbone structure, allowing for various chemical modifications that enhance its therapeutic potential.
Career Highlights
Albert Sun-chi Chan is affiliated with The Hong Kong Polytechnic University, where he conducts his research and development activities. His work is characterized by a strong emphasis on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.
Collaborations
Chan collaborates with esteemed colleagues, including Johnny Cheuk-on Tang and Kim-hung Lam. Their combined expertise contributes to the success of their research initiatives and the development of new therapeutic agents.
Conclusion
Albert Sun-chi Chan's contributions to cancer research through his patented inventions highlight his role as a leading innovator in the field. His work not only advances scientific knowledge but also holds the potential to improve treatment options for patients suffering from cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
